|
Shertech’s Operations Halted by 483 Citing Procedural Lapses
Shertech Laboratories received a Form 483 after investigators found an array of procedural lapses that ultimately led the company to halt its first try at manufacturing prescription generics.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives